These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35177698)

  • 1. The spectrum of comorbidities at the initial diagnosis of heart failure a case control study.
    Loosen SH; Roderburg C; Curth O; Gaensbacher J; Joerdens M; Luedde T; Konrad M; Kostev K; Luedde M
    Sci Rep; 2022 Feb; 12(1):2670. PubMed ID: 35177698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preheart failure comorbidities and impact on prognosis in heart failure patients: a nationwide study.
    Christiansen MN; Køber L; Torp-Pedersen C; Gislason GH; Schou M; Smith JG; Vasan RS; Andersson C
    J Intern Med; 2020 Jun; 287(6):698-710. PubMed ID: 32103571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart failure is associated with an increased incidence of cancer diagnoses.
    Roderburg C; Loosen SH; Jahn JK; Gänsbacher J; Luedde T; Kostev K; Luedde M
    ESC Heart Fail; 2021 Oct; 8(5):3628-3633. PubMed ID: 34180146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity profile and outcomes in patients with chronic heart failure in a Latin American country: Insights from the Colombian heart failure registry (RECOLFACA).
    Campbell-Quintero S; Echeverría LE; Gómez-Mesa JE; Rivera-Toquica A; Rentería-Asprilla CA; López-Garzón NA; Alcalá-Hernández AE; Accini-Mendoza JL; Baquero-Lozano GA; Martínez-Carvajal AR; Cadena A; Zarama-Márquez MH; Ramírez-Puentes EG; Bustamante RI; Saldarriaga C
    Int J Cardiol; 2023 May; 378():123-129. PubMed ID: 36791963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention.
    Khazanie P; Hellkamp AS; Fonarow GC; Bhatt DL; Masoudi FA; Anstrom KJ; Heidenreich PA; Yancy CW; Curtis LH; Hernandez AF; Peterson ED; Al-Khatib SM
    J Am Heart Assoc; 2015 Aug; 4(8):e002061. PubMed ID: 26251283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver Disease (NAFLD) and risk of new-onset heart failure: a retrospective analysis of 173,966 patients.
    Roderburg C; Krieg S; Krieg A; Vaghiri S; Mohr R; Konrad M; Luedde M; Luedde T; Kostev K; Loosen SH
    Clin Res Cardiol; 2023 Oct; 112(10):1446-1453. PubMed ID: 37410163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.
    Ergatoudes C; Schaufelberger M; Andersson B; Pivodic A; Dahlström U; Fu M
    Clin Res Cardiol; 2019 Sep; 108(9):1025-1033. PubMed ID: 30788622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Diabetes Mellitus and Impact of Heart Failure on Prognosis Compared to Other Cardiovascular Diseases: A Nationwide Study.
    Zareini B; Blanche P; D'Souza M; Elmegaard Malik M; Nørgaard CH; Selmer C; Gislason G; Kristensen SL; Køber L; Torp-Pedersen C; Schou M; Lamberts M
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006260. PubMed ID: 32571092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure in primary care: prevalence related to age and comorbidity.
    Bosch L; Assmann P; de Grauw WJC; Schalk BWM; Biermans MCJ
    Prim Health Care Res Dev; 2019 Jul; 20():e79. PubMed ID: 31868152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased comorbidities in heart failure patients ≥ 85 years but declined from >90 years: data from the Swedish Heart Failure Registry.
    Holmström A; Sigurjonsdottir R; Edner M; Jonsson A; Dahlström U; Fu ML
    Int J Cardiol; 2013 Sep; 167(6):2747-52. PubMed ID: 22805544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity in patients with heart failure from 11 Asian regions: A prospective cohort study using the ASIAN-HF registry.
    Tromp J; Tay WT; Ouwerkerk W; Teng TK; Yap J; MacDonald MR; Leineweber K; McMurray JJV; Zile MR; Anand IS; Richards AMR; Lam CSP;
    PLoS Med; 2018 Mar; 15(3):e1002541. PubMed ID: 29584721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in Heart Failure Across the Ejection Fraction Spectrum: Phenotyping, and Prognostic and Therapeutic Implications.
    Stolfo D; Uijl A; Vedin O; Strömberg A; Faxén UL; Rosano GMC; Sinagra G; Dahlström U; Savarese G
    JACC Heart Fail; 2019 Jun; 7(6):505-515. PubMed ID: 31146874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Spectrum of Co-Diagnoses in Patients with Colorectal Cancer: A Retrospective Cohort Study of 17,824 Outpatients in Germany.
    Loosen SH; Schöler D; Labuhn S; Mertens A; Jördens MS; Luedde M; Kostev K; Luedde T; Roderburg C
    Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954488
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis, Clinical Course, and 1-Year Outcome in Patients Hospitalized for Heart Failure With Preserved Ejection Fraction (from the Polish Cohort of the European Society of Cardiology Heart Failure Long-Term Registry).
    Kapłon-Cieślicka A; Tymińska A; Peller M; Balsam P; Ozierański K; Galas M; Marchel M; Crespo-Leiro MG; Maggioni AP; Drożdż J; Filipiak KJ; Opolski G
    Am J Cardiol; 2016 Aug; 118(4):535-42. PubMed ID: 27374606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome and presentation of heart failure in breast cancer patients: findings from a Swedish register-based study.
    Hedayati E; Papakonstantinou A; Gernaat SAM; Altena R; Brand JS; Alfredsson J; Bhoo-Pathy N; Herrmann J; Linde C; Dahlstrom U; Bergh J; Hubbert L
    Eur Heart J Qual Care Clin Outcomes; 2020 Apr; 6(2):147-155. PubMed ID: 31328233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study.
    Zareini B; Rørth R; Holt A; Mogensen UM; Selmer C; Gislason G; Schou M; Køber L; Torp-Pedersen C; Lamberts M; Kristensen SL
    Cardiovasc Diabetol; 2019 Jun; 18(1):79. PubMed ID: 31189473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
    Salz T; Zabor EC; de Nully Brown P; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Vickers AJ; Svenssen Munksgaard P; Oeffinger KC; Johansen C
    J Clin Oncol; 2017 Dec; 35(34):3837-3843. PubMed ID: 28922087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body surface area as a prognostic marker in chronic heart failure patients: results from the Heart Failure Registry of the Heart Failure Association of the European Society of Cardiology.
    Zafrir B; Salman N; Crespo-Leiro MG; Anker SD; Coats AJ; Ferrari R; Filippatos G; Maggioni AP; Mebazaa A; Piepoli MF; Ruschitzka F; Paniagua-Martin MJ; Segovia J; Laroche C; Amir O;
    Eur J Heart Fail; 2016 Jul; 18(7):859-68. PubMed ID: 27198159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalent Diabetes Mellitus: Mortality and Management in Norwegian Heart Failure Outpatients.
    Stubnova V; Os I; Grundtvig M; Waldum-Grevbo B
    Cardiology; 2016; 134(4):413-22. PubMed ID: 27120050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Determinants, and Prognostic Significance of Pulmonary Hypertension in Elderly Patients Admitted with Acute Decompensated Heart Failure: A Report from the BIO-HF Registry.
    Vanhercke D; Pardaens S; Weytjens C; Vande Kerckhove B; De Laet N; Janssens E; Van Camp G; De Sutter J
    Echocardiography; 2015 Sep; 32(9):1333-8. PubMed ID: 25470753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.